Fragment-based drug discovery (FBDD) is playing an increasingly important part in delivering candidates to the clinic. Compared with screens of lead- or drug-sized molecules, fragments allow for a ...
This protocol describes the screening of a library of low-molecular-weight compounds (fragments) using a series of biophysical ligand-binding assays. Fragment-based drug discovery (FBDD) has emerged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback